Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

TLR7 agonist RO7020531 versus placebo in healthy volunteers and patients with chronic hepatitis B virus infection: a randomised, observer-blind, placebo-controlled, phase 1 trial.

Autor: Yuen MF; Department of Medicine, Queen Mary Hospital, School of Clinical Medicine and State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong Special Administrative Region, China., Balabanska R; Clinic of Gastroenterology, Acibadem City Clinic Tokuda Hospital, Sofia, Bulgaria., Cottreel E; Roche Pharma Research and Early Development, Roche Innovation Center, Basel, Switzerland., Chen E; Roche Pharma Product Development China, Shanghai, China., Duan D; Roche Pharma Research and Early Development, Roche Innovation Center, Shanghai, China., Jiang Q; Roche Pharma Research and Early Development, Roche Innovation Center, Shanghai, China., Patil A; Product Development Data Science Department, Roche Products, Welwyn, UK., Triyatni M; Roche Pharma Research and Early Development, Roche Innovation Center, Basel, Switzerland., Upmanyu R; Product Development Data Science Department, Roche Products, Welwyn, UK., Zhu Y; Roche Pharma Research and Early Development, Roche Innovation Center, Shanghai, China., Canducci F; Roche Pharma Research and Early Development, Roche Innovation Center, Basel, Switzerland. Electronic address: filippo.canducci@gmail.com., Gane EJ; Faculty of Medicine, University of Auckland, Auckland, New Zealand.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Apr; Vol. 23 (4), pp. 496-507. Date of Electronic Publication: 2022 Dec 09.

High-Density Lipoprotein Subclasses and Their Role in the Prevention and Treatment of Cardiovascular Disease: A Narrative Review.

Autor: Chen, Qiaofei^1,2,3 (AUTHOR) chenqf56@mail2.sysu.edu.cn, Abudukeremu, Ayiguli^1,2,3 (AUTHOR) ayglabdkrm@163.com, Li, Kaiwen⁴ (AUTHOR) likw9@mail2.sysu.edu.cn, Zheng, Minglong¹ (AUTHOR) zhengmlong3@mail2.sysu.edu.cn, Li, Hongwei¹ (AUTHOR) lihw57@mail2.sysu.edu.cn, Huang, Tongsheng¹ (AUTHOR) huangtsh3@mail2.sysu.edu.cn, Huang, Canxia¹ (AUTHOR) huangcx5@mail.sysu.edu.cn, Wen, Kexin¹ (AUTHOR) wenkx@mail2.sysu.edu.cn, Wang, Yue¹ (AUTHOR) wangy2323@mail2.sysu.edu.cn, Zhang, Yuling^1,2,3,5 (AUTHOR) zhyul@mail.sysu.edu.cn

Publikováno v: International Journal of Molecular Sciences. Jul2024, Vol. 25 Issue 14, p7856. 19p.

Hepatitis B: Model Systems and Therapeutic Approaches.

Autor: Yu, Xiaoxiao¹ (AUTHOR), Gao, Yating¹ (AUTHOR), Zhang, Xin¹ (AUTHOR), Ji, Longshan¹ (AUTHOR), Fang, Miao¹ (AUTHOR), Li, Man¹ (AUTHOR), Gao, Yueqiu^1,2,3 (AUTHOR)

Publikováno v: Journal of Immunology Research. 5/7/2024, Vol. 2024, p1-15. 15p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.